Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
Condition(s):Group B Streptococcal InfectionsLast Updated:June 9, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Group B Streptococcal InfectionsLast Updated:June 9, 2023Active, not recruiting
Condition(s):Healthy VolunteersLast Updated:January 14, 2019Terminated
Condition(s):Safety; Tolerability; Pharmacokinetics; Healthy ParticipantsLast Updated:December 8, 2022Completed
Condition(s):Axial SpondyloarthritisLast Updated:January 13, 2021Completed
Condition(s):HealthyLast Updated:August 4, 2015Completed
Condition(s):HealthyLast Updated:April 21, 2015Completed
Condition(s):Hypothyroidism; Trisomy 21Last Updated:September 13, 2023Terminated
Condition(s):Safety; Tolerability; Pharmacokinetics; Healthy SubjectsLast Updated:April 28, 2017Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:August 5, 2019Completed
Condition(s):Alzheimer DiseaseLast Updated:September 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.